TD Asset Management Inc Raises Stake in Henry Schein, Inc. (NASDAQ:HSIC)

TD Asset Management Inc boosted its holdings in Henry Schein, Inc. (NASDAQ:HSICFree Report) by 8.6% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 35,644 shares of the company’s stock after purchasing an additional 2,812 shares during the quarter. TD Asset Management Inc’s holdings in Henry Schein were worth $2,699,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in HSIC. McGlone Suttner Wealth Management Inc. bought a new position in Henry Schein during the 4th quarter valued at approximately $39,000. Neo Ivy Capital Management bought a new position in shares of Henry Schein during the third quarter valued at $46,000. Covestor Ltd raised its position in shares of Henry Schein by 22.8% in the 3rd quarter. Covestor Ltd now owns 1,367 shares of the company’s stock worth $102,000 after purchasing an additional 254 shares during the last quarter. Benjamin F. Edwards & Company Inc. boosted its stake in Henry Schein by 37.8% in the 4th quarter. Benjamin F. Edwards & Company Inc. now owns 1,516 shares of the company’s stock worth $114,000 after purchasing an additional 416 shares in the last quarter. Finally, GAMMA Investing LLC purchased a new stake in Henry Schein during the 4th quarter valued at about $115,000. Institutional investors own 96.62% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages have issued reports on HSIC. Barrington Research lifted their target price on shares of Henry Schein from $90.00 to $92.00 and gave the stock an “outperform” rating in a report on Wednesday, May 8th. Piper Sandler increased their target price on Henry Schein from $78.00 to $86.00 and gave the company an “overweight” rating in a research note on Monday, February 26th. SVB Leerink assumed coverage on Henry Schein in a research note on Monday, February 26th. They issued a “market perform” rating and a $78.00 price target for the company. TheStreet raised Henry Schein from a “c+” rating to a “b-” rating in a research report on Monday, February 26th. Finally, UBS Group decreased their target price on Henry Schein from $82.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday, May 8th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $81.73.

Get Our Latest Report on HSIC

Henry Schein Trading Down 0.1 %

Shares of Henry Schein stock opened at $68.51 on Friday. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $82.63. The company’s fifty day simple moving average is $71.73 and its 200-day simple moving average is $73.20. The company has a debt-to-equity ratio of 0.47, a current ratio of 1.75 and a quick ratio of 1.02. The stock has a market capitalization of $8.77 billion, a PE ratio of 23.15, a P/E/G ratio of 1.74 and a beta of 0.90.

Henry Schein (NASDAQ:HSICGet Free Report) last released its earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.01 by $0.09. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.21 billion. During the same period in the previous year, the business earned $1.21 earnings per share. Henry Schein’s quarterly revenue was up 3.7% compared to the same quarter last year. As a group, equities analysts anticipate that Henry Schein, Inc. will post 5.09 earnings per share for the current year.

Insider Buying and Selling

In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of Henry Schein stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the transaction, the chief executive officer now owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the sale, the chief executive officer now owns 73,108 shares in the company, valued at approximately $5,430,462.24. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the business’s stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the transaction, the insider now owns 209,562 shares in the company, valued at $15,585,125.94. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Henry Schein Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Stories

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.